Yi Lin
MD PhD
Associate Professor
👥Biography 个人简介
Yi Lin at Mayo Clinic has contributed to the development and clinical evaluation of BCMA-targeted therapies for myeloma, including idecabtagene vicleucel (ide-cel, KarMMA trial) and ciltacabtagene autoleucel (cilta-cel, CARTITUDE-1/4 trials) — CAR-T cell therapies that have revolutionized treatment of relapsed/refractory myeloma. The deep and durable responses seen with BCMA CAR-T have transformed outcomes for heavily pre-treated myeloma patients.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Yi Lin 的研究动态
Follow Yi Lin's research updates
留下邮箱，当我们发布与 Yi Lin（Mayo Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment